KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $207.1 million.

  • Charles River Laboratories International's Cash & Equivalents fell 1.46% to $207.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.1 million, marking a year-over-year decrease of 1.46%. This contributed to the annual value of $194.6 million for FY2024, which is 29.69% down from last year.
  • Per Charles River Laboratories International's latest filing, its Cash & Equivalents stood at $207.1 million for Q3 2025, which was up 13.28% from $182.8 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Cash & Equivalents ranged from a high of $465.4 million in Q1 2021 and a low of $157.2 million during Q3 2023.
  • Its 3-year average for Cash & Equivalents is $215.1 million, with a median of $201.6 million in 2023.
  • As far as peak fluctuations go, Charles River Laboratories International's Cash & Equivalents slumped by 48.03% in 2022, and later spiked by 62.23% in 2024.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Cash & Equivalents stood at $241.2 million in 2021, then dropped by 3.03% to $233.9 million in 2022, then climbed by 18.32% to $276.8 million in 2023, then fell by 29.69% to $194.6 million in 2024, then declined by 1.46% to $207.1 million in 2025.
  • Its last three reported values are $207.1 million in Q3 2025, $182.8 million for Q2 2025, and $229.4 million during Q1 2025.